Old Web
English
Sign In
Acemap
>
authorDetail
>
Ximena Galindo-Orrego
Ximena Galindo-Orrego
Grupo México
Medicine
HIV/AIDS
Abacavir
Clinical trial
Abacavir/Lamivudine
3
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Scales to Assess Knowledge, Motivation, and Self-Efficacy for HIV PrEP in Colombian MSM: PrEP-COL Study.
2021
Aids Research and Treatment
Hector Fabio Mueses Marín
Beatriz Alvarado Llano
Julian Torres-Isasiga
Pilar Camargo Plazas
Maria C. Bolívar-Rocha
Ximena Galindo-Orrego
Jorge L. Martinez-Cajas
Show All
Source
Cite
Save
Citations (0)
Resistencia a la terapia antirretroviral (TAR) en pacientes VIH/SIDA en fracaso terapéutico, Cali-Colombia
2019
Lina María Agudelo-Rojas
María Victoria Coral-Orbes
Ximena Galindo-Orrego
Hector Fabio Mueses Marín
Jaime Galindo Quintero
Show All
Source
Cite
Save
Citations (0)
Effectiveness and safety of generic version of abacavir/lamivudine and efavirenz in treatment naïve HIV-infected patients: a nonrandomized, open-label, phase IV study in Cali-Colombia, 2011–2012
2016
BMC Infectious Diseases
Jaime Galindo
Pedro Amariles
Hector Fabio Mueses Marín
Jaime A. Hincapié
Sebastián González-Avendaño
Ximena Galindo-Orrego
Show All
Source
Cite
Save
Citations (3)
1